[1] 王丽萍, 张月, 孙滨州, 等. 120例女性宫颈病变患者HPV感染的基因型分布和病理特征分析[J/CD].新发传染病电子杂志, 2024, 9(4): 23-28. [2] PALMER TJ, KAVANAGH K, CUSCHIERI K, et al.Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation[J].J Natl Cancer Inst, 2024, 116(6): 857-865. [3] JHA AK, MITHUN S, SHERKHANE UB, et al.Systematic review and meta-analysis of prediction models used in cervical cancer[J].Artif Intell Med,2023,139(6):102549. [4] 王巧祎, 赵希芹, 郭雨辰, 等. HPV52 E6和E7基因多态性与宫颈上皮内瘤变相关性[J].青岛大学学报(医学版), 2022, 58(5): 667-671. [5] 张莹, 曾妍茗, 鲁雁秋, 等. 人乳头瘤病毒疫苗接种预防感染及相关癌症的研究进展[J/CD].新发传染病电子杂志, 2023, 8(6): 84-88. [6] 万章彩, 杨洁, 陈坤菊, 等. 中期宫颈癌患者术后血清Chemerin,Hmga1水平变化及对2年内复发的影响[J].中国性科学, 2023, 32(12): 90-94. [7] 史中娜, 王宝金, 白杨, 等. 高危HPV载量与血清FSTL1,TGF-β1水平联合检测对宫颈病变的预测价值[J].中国卫生检验杂志, 2023, 33(16): 2008-2011. [8] 李静, 索红燕, 孔为民. 《国际妇产科联盟(FIGO)2018癌症报告:宫颈癌新分期及诊治指南》解读[J].中国临床医生杂志, 2019, 47(6): 646-649. [9] 茅娅男, 尤志学. ASCCP 2019共识指南子宫颈癌前病变管理解读[J].现代妇产科进展, 2020, 29(12): 936-941. [10] LEI J, ARROYO-MÜHR LS, LAGHEDEN C, et al. Human Papillomavirus Infection Determines Prognosis in Cervical Cancer[J].J Clin Oncol, 2022, 40(14): 1522-1528. [11] SINGINI MG, SINGH E, BRADSHAW D, et al.Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis[J].J Med Virol, 2023, 95(1): e27900. [12] BHATTACHARJEE R, DAS SS, BISWAL SS, et al.Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies[J].Crit Rev Oncol Hematol, 2022, 174(6): 103675. [13] 杜靖, 李晨, 王晓静, 等.白介素-2和信号转导和转录激活因子5在宫颈病变患者血清,宫颈组织和细胞中的表达及意义[J].新乡医学院学报, 2022, 39(10): 934-941. [14] GAN J, DI XH, YAN ZY, et al.HLA-G 3'UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis[J].Front Immunol, 2022, 13(3): 1076040. [15] HE Z, JING X, DAI X, et al.The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma[J].Front Biosci (Landmark Ed), 2024, 29(4): 158. [16] LIU P, PEI JJ, LI L, et al.Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway[J].Curr Cancer Drug Targets, 2023, 23(2): 145-158. [17] BOWDEN SJ, DOULGERAKI T, BOURAS E, et al.Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies[J].BMC Med, 2023, 21(1): 274. [18] XU HH, XIE YY, JUN-GAN, et al.Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy[J].J Cancer Res Clin Oncol, 2023, 149(8): 4195-4204. [19] 徐菁华, 李吉. SPP1与PI3K在宫颈癌细胞中的表达及临床意义[J].药物生物技术, 2024, 31(2): 171-174. [20] 陈丽艳, 姜继勇, 刘莎, 等. 宫颈癌患者高危型HPV感染状况及与血清HLA-G、TGF-β1表达的相关性[J].临床和实验医学杂志, 2022, 21(3): 295-299. |